Gregg W Stone. The Lancet, Early Online Publication, 14 January 2010
Tremendous progress has been achieved over the past decade in the treatment of acute coronary syndromes (ST-segment elevation myocardial infarction [STEMI ] , non-STEMI [NSTEMI ] , and unstable angina).
In STEMI, primary percutaneous coronary intervention compared with fibrinolytic therapy reduces mortality, reinfarction, stroke, infarct size, and recurrent ischaemia. 1 In moderate-risk and high-risk patients with NSTEMI, early angiography followed by revascularisation with either percutaneous coronar …
Weblink here